Literature DB >> 6088629

Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.

O Saiki, M Shimizu, Y Saeki, S Kishimoto, T Kishimoto.   

Abstract

In the course of an analysis of lymphocyte functions of common variable immunodeficiency patients, we found one patient whose T lymphocytes released B cell differentiation factor (BCDF) and B cell growth factor (BCGF) without IL 2 production upon stimulation with Con A. The patient was a 68-yr-old woman with hypo-gamma-globulinemia (IgM: 31 mg/dl, IgG: 223 mg/dl, IgA: 23 mg/dl); she suffered from cryptococcal meningitis and pulmonary tuberculosis with a negative result of skin tests to PPD and cryptococcal antigen. The number of T cells and the ratio of T cell subsets (Leu-2a and Leu-3a) was normal. T cells showed no proliferative response to Con A and a low response to PHA (one-tenth of normal response). The addition of patient T cells to normal T cells did not inhibit the proliferation of normal T cells when stimulated by Con A. The culture supernatant of Con A-stimulated T cells contained no IL 2 activity when assayed by an IL 2-dependent T cell line. Expression of Tac antigen was not impaired by Con A stimulation and the addition of partially purified IL 2 from the supernatant of Jurkat T cell line-induced proliferation of Con A-stimulated T cells, indicating that the defect observed was not in IL 2-responding cells but in IL 2-producing cells. In contrast, the culture supernatant of the T cells stimulated by Con A or PHA contained BCDF activity as much as that of normal T cells when assayed by Cowan I-stimulated normal B cells or the B lymphoblastoid cell line SKW6-CL4. The supernatant also contained BCGF activity. These results suggest that B cell-stimulating factor (BCGF, BCDF) and IL 2 may be synthesized by different subsets of T cells or that the synthesis of those lymphokines are independently regulated in the same cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088629

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Severe T lymphocyte immunodeficiency associated with hypogammaglobulinemia: defective lymphokine secretion but enhanced autologous mixed lymphocyte reaction.

Authors:  S Raziuddin; B Teklu
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

2.  Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; F Rousset; J Pene; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

3.  Recombinant interleukin 2 therapy in severe combined immunodeficiency disease.

Authors:  R Pahwa; T Chatila; S Pahwa; C Paradise; N K Day; R Geha; S A Schwartz; H Slade; N Oyaizu; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  The capacity of interleukin-4 to induce in vitro IgE synthesis by B cells of patients with common variable immunodeficiency.

Authors:  G Pastorelli; M G Roncarolo; C Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1990-10       Impact factor: 4.330

5.  Immune responses in newly developed short-lived SAM mice. Selectively impaired T-helper cell activity in in vitro antibody response.

Authors:  T Hosokawa; M Hosono; K Hanada; A Aoike; K Kawai; T Takeda
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

6.  Increased IL-6 gene expression and production in patients with common variable immunodeficiency.

Authors:  F Pandolfi; R Paganelli; A Oliva; I Quinti; V Polidori; E Fanales-Belasio; E Guerra; F Aiuti
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

7.  Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens.

Authors:  M E North; G P Spickett; J Allsop; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

8.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 9.  Administration of recombinant IL-2 augments the level of serum IgM in an IL-2 deficient patient.

Authors:  S Doi; O Saiki; T Hara; T Sugita; K Ha-Kawa; T Tanaka; H Hara; S Negoro; H Yabuuchi; S Kishimoto
Journal:  Eur J Pediatr       Date:  1989-06       Impact factor: 3.183

10.  Peripheral T-cell lymphomas. Immunophenotype, lymphokine production, and immunologic functional characteristics of the lymph-node malignant T cells.

Authors:  S Raziuddin; T Malatani; S al-Sedairy; A H al-Saigh
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.